Kimberly A. Chianese‐Bullock

机构：University of Virginia Health System, University of Virginia · ORCID：0000-0001-8676-3671

发表论文 141 篇 · 总被引 3048 次 · h-index 30

代表论文

Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial (2024 · Nature Communications · 被引 32)
Stability of Multi-Peptide Vaccines in Conditions Enabling Accessibility in Limited Resource Settings (2024 · International Journal of Peptide Research and Therapeutics · 被引 5)
Twenty‐year survival outcomes after multipeptide vaccination for resected high‐risk melanoma: A post‐hoc analysis of a randomized clinical trial (2025 · International Journal of Cancer · 被引 3)
1466 Phase I/II clinical trial of a melanoma vaccine targeting shared nonmutated antigens and a shared mutated neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR agonist (polyICLC) (2024 · 被引 3)
Phase I/II clinical trial of a melanoma vaccine targeting shared non-mutated antigens and a shared mutated BRAF neoantigen with an agonistic CD40 antibody (CDX-1140) plus TLR3 agonist (poly-ICLC) (2026 · Journal for ImmunoTherapy of Cancer · 被引 2)
Table 1 from Randomized Phase I/II Clinical Trial of a Melanoma Helper Peptide Vaccine with or without Systemic Agonistic Anti-CD27 Antibody (Varlilumab) (2026)